Related Experiment Video
Updated: Aug 15, 2026
06:34
A Component-resolved Diagnostic Approach for a Study on Grass Pollen Allergens in Chinese Southerners with Allergic Rhinitis and/or Asthma
Published on: June 4, 2017
Beta2-ADR haplotypes/polymorphisms associate with bronchodilator response and total IgE in grass allergy
G Woszczek1, M Borowiec, A Ptasinska
1Department of Clinical Immunology and Allergy, Medical University of Lodz, Lodz, Poland.
Allergy
|October 4, 2005
Summary
Specific beta2-adrenergic receptor (beta2-ADR) gene variations, including single nucleotide polymorphisms (SNPs) and haplotypes, influence bronchodilator response and total immunoglobulin E (IgE) levels in asthma patients. These genetic factors may impact asthma manifestation depending on the studied phenotype.
Area of Science:
- Pharmacogenetics
- Immunogenetics
- Respiratory Medicine
Background:
- Beta2-adrenergic receptor (beta2-ADR) gene polymorphisms have been inconsistently linked to asthma phenotypes and immune responses.
- Understanding the role of specific beta2-ADR genetic variations is crucial for personalized asthma management.
Purpose of the Study:
- To investigate the association between beta2-ADR gene single nucleotide polymorphisms (SNPs) and haplotypes with bronchial asthma, bronchodilator response, and total immunoglobulin E (IgE) levels.
- To analyze the relevance of specific combinations of beta2-ADR SNPs (haplotypes) in Caucasian subjects.
Main Methods:
- Direct DNA sequencing was used to identify five SNPs in the beta2-ADR gene (-47, -20, 46, 79, 252) in 180 Caucasian subjects (110 with grass allergy, 70 controls).
- Eight distinct beta2-ADR haplotypes were identified, with the three most common comprising 92% of the cohort.
- Statistical analyses (pcor) were performed to assess associations between genotypes, haplotypes, bronchodilator response, and total IgE levels.
Main Results:
- Significantly higher bronchodilator response was observed in patients with the 46A/A homozygotic genotype (pcor = 0.0045).
- Total IgE levels were significantly higher in patients with the beta2-ADR haplotype -47T/-20T/46A/79C/252G (pcor = 0.0005), and homozygotic carriers of 46A (pcor = 0.0015) and 79C (pcor = 0.003) genotypes.
- No significant associations were found regarding asthmatic phenotype and atopy, nor for bronchodilator response when analyzing beta2-ADR haplotypes.
Conclusions:
- Individual beta2-ADR SNPs, specifically the 46A/A genotype and 79C genotype, are associated with increased total IgE levels and bronchodilator response.
- A specific beta2-ADR haplotype (-47T/-20T/46A/79C/252G) is linked to elevated total IgE levels.
- These findings suggest that specific beta2-ADR genetic variations, rather than haplotypes, may influence asthma-related traits like bronchodilator response and IgE levels, depending on the phenotype studied.
Related Concept Videos
02:06Allergic Reactions
Overview
01:31Adrenergic Receptors: ɑ Subtype
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
01:26Adrenergic Receptors: β Subtype
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...